Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial results for the fourth quarter and full year 2024 after market close on Tuesday, February 18 ...
Expert Rev Cardiovasc Ther. 2009;7(1):29-48. Several additional trials are using identification of a penumbra by neuroimaging for the inclusion of patients. The ReoPro Retavase Reperfusion of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback